Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 35287 [2018-15884]

Download as PDF Federal Register / Vol. 83, No. 143 / Wednesday, July 25, 2018 / Notices the public interest. No petitions for review of the subject ID were filed. The Commission has determined not to review the subject ID and has issued the consent orders. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: July 20, 2018. Lisa Barton, Secretary to the Commission. Unemployment Insurance, Room S–4524, Attn: Anatoli Sznoluch, 200 Constitution Avenue NW, Washington, DC 20210, telephone number (202) 693– 3176 (this is not a toll-free number) or by email: Sznoluch.Anatoli@dol.gov. Rosemary Lahasky, Deputy Assistant Secretary, Employment and Training, Labor. [FR Doc. 2018–15910 Filed 7–24–18; 8:45 am] BILLING CODE 4510–FT–P NUCLEAR REGULATORY COMMISSION [FR Doc. 2018–15930 Filed 7–24–18; 8:45 am] Advisory Committee on the Medical Uses of Isotopes: Meeting Notice BILLING CODE 7020–02–P U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: DEPARTMENT OF LABOR Employment and Training Administration Notice of a Change in Status of an Extended Benefit (EB) Period for the United States Virgin Islands Employment and Training Administration, Labor. ACTION: Notice. AGENCY: This notice announces a change in benefit period eligibility under the EB program for the Virgin Islands. The following change has occurred since the publication of the last notice regarding the Virgin Islands’ EB status: • The Virgin Islands’ 13-week insured unemployment rate for the week ending June 2, 2018, was below the 5.00 percent threshold. Therefore, the EB period for the Virgin Islands will end on June 23, 2018. The State will remain in an ‘‘off’’ period for a minimum of 13 weeks. SUMMARY: daltland on DSKBBV9HB2PROD with NOTICES Information for Claimants The duration of benefits payable in the EB Program, and the terms and conditions on which they are payable, are governed by the Federal-State Extended Unemployment Compensation Act of 1970, as amended, and the operating instructions issued to the states by the U.S. Department of Labor. In the case of a state ending an EB period, the State Workforce Agency will furnish a written notice to each individual who is currently filing claims for EB of the forthcoming termination of the EB period and its effect on the individual’s right to EB (20 CFR 615.13 (c)). FOR FURTHER INFORMATION CONTACT: U.S. Department of Labor, Employment and Training Administration, Office of VerDate Sep<11>2014 18:50 Jul 24, 2018 The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on September 20–21, 2018. Tentative agenda items to be discussed during the public session include: (1) Medicalrelated events; (2) an update on nursing mother guidelines; (3) licensing of thorium-227 chloride; (4) an update on the yttrium-90 microspheres licensing guidance revision; and (5) status of the NRC’s training and experience (T&E) evaluation and stakeholder outreach plans for T&E. The agenda is subject to change. The current agenda and any updates will be available at https:// www.nrc.gov/reading-rm/doccollections/acmui/meetings/2018.html or may be requested by emailing Ms. Lisa Dimmick at the contact information below. Purpose: Discuss issues related to 10 CFR part 35, Medical Use of Byproduct Material. Date and Time for Open Sessions: September 20, 2018, from 8:30 a.m. to 3:00 p.m. and September 21, 2018, from 8:30 a.m. to 3:30 p.m. Eastern Standard Time. Date and Time for Closed Sessions: September 20, 2018, from 8:00 a.m. to 8:30 a.m. and 3:30 p.m. to 5:00 .pm. Address for Public Meeting: U.S. Nuclear Regulatory Commission, One White Flint North Building, Commission Hearing Room, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Dimmick using the information below. The meeting will also be webcast live at https:// video.nrc.gov/. SUMMARY: Jkt 244001 PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 35287 Contact Information: Lisa Dimmick, email: lisa.dimmick@nrc.gov, telephone: (301) 415–0694. Conduct of the Meeting Christopher J. Palestro, M.D. will chair the meeting. Dr. Palestro will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Dimmick using the contact information listed above. All submittals must be received by September 17, 2018, three business days before the meeting, and must pertain to the topics on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s website https://www.nrc.gov/reading-rm/ doc-collections/acmui/meetings/ 2018.html on or about November 2, 2018. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Dimmick of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in title 10 of the Code of Federal Regulations, part 7. Dated at Rockville, Maryland, this 20th day of July 2018. For the Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2018–15884 Filed 7–24–18; 8:45 am] BILLING CODE 7590–01–P POSTAL REGULATORY COMMISSION [Docket Nos. CP2017–203; MC2018–193 and CP2018–271; MC2018–194 and CP2018–272; MC2018–195 and CP2018–273] New Postal Products Postal Regulatory Commission. Notice. AGENCY: ACTION: The Commission is noticing a recent Postal Service filing for the Commission’s consideration concerning negotiated service agreements. This notice informs the public of the filing, invites public comment, and takes other administrative steps. SUMMARY: E:\FR\FM\25JYN1.SGM 25JYN1

Agencies

[Federal Register Volume 83, Number 143 (Wednesday, July 25, 2018)]
[Notices]
[Page 35287]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15884]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
meeting of the Advisory Committee on the Medical Uses of Isotopes 
(ACMUI) on September 20-21, 2018. Tentative agenda items to be 
discussed during the public session include: (1) Medical-related 
events; (2) an update on nursing mother guidelines; (3) licensing of 
thorium-227 chloride; (4) an update on the yttrium-90 microspheres 
licensing guidance revision; and (5) status of the NRC's training and 
experience (T&E) evaluation and stakeholder outreach plans for T&E. The 
agenda is subject to change. The current agenda and any updates will be 
available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html or may be requested by emailing Ms. Lisa Dimmick at 
the contact information below.
    Purpose: Discuss issues related to 10 CFR part 35, Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: September 20, 2018, from 8:30 a.m. 
to 3:00 p.m. and September 21, 2018, from 8:30 a.m. to 3:30 p.m. 
Eastern Standard Time.
    Date and Time for Closed Sessions: September 20, 2018, from 8:00 
a.m. to 8:30 a.m. and 3:30 p.m. to 5:00 .pm.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, One 
White Flint North Building, Commission Hearing Room, 11545 Rockville 
Pike, Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Dimmick using the information below. The meeting will also be webcast 
live at https://video.nrc.gov/.
    Contact Information: Lisa Dimmick, email: [email protected], 
telephone: (301) 415-0694.

Conduct of the Meeting

    Christopher J. Palestro, M.D. will chair the meeting. Dr. Palestro 
will conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Dimmick using the contact information listed 
above. All submittals must be received by September 17, 2018, three 
business days before the meeting, and must pertain to the topics on the 
agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html on or about November 2, 2018.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Dimmick of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in title 
10 of the Code of Federal Regulations, part 7.

    Dated at Rockville, Maryland, this 20th day of July 2018.

    For the Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2018-15884 Filed 7-24-18; 8:45 am]
 BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.